TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study).

Lilian Schwarz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.